MedPath

NSABP FOUNDATION, INC.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.foundation.nsabp.org

Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

Conditions
Breast Cancer
First Posted Date
2011-08-19
Last Posted Date
2015-05-08
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
1300
Registration Number
NCT01420185

Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer

Completed
Conditions
Breast Cancer
First Posted Date
2011-07-21
Last Posted Date
2021-10-05
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
1023
Registration Number
NCT01399359
Locations
🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Conditions
Fatigue
Breast Cancer
Depression
Sleep Disorders
Interventions
Drug: Placebo
First Posted Date
2011-01-31
Last Posted Date
2015-09-09
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
394
Registration Number
NCT01286233
Locations
🇺🇸

Kaiser Permanente Medical Center - Anaheim/Orange County, Anaheim, California, United States

🇺🇸

Kaiser Permanente - Deer Valley, Antioch, California, United States

🇺🇸

Kaiser Permanente Medical Center - Baldwin Park, Baldwin Park, California, United States

and more 251 locations

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Phase 3
Terminated
Conditions
Colorectal Cancer
Metastatic Cancer
First Posted Date
2010-08-26
Last Posted Date
2013-05-10
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
9
Registration Number
NCT01189227
Locations
🇺🇸

Kaiser Permanente - Deer Valley, Antioch, California, United States

🇺🇸

City of Hope Comprehensive Cancer Center, Duarte, California, United States

🇺🇸

Kaiser Permanente - Fremont, Fremont, California, United States

and more 278 locations

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Phase 3
Terminated
Conditions
Colorectal Cancer
Precancerous Condition
Interventions
Other: placebo
First Posted Date
2009-11-11
Last Posted Date
2023-08-16
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
406
Registration Number
NCT01011478
Locations
🇺🇸

Regional Medical Center, Anniston, Alabama, United States

🇺🇸

Providence Cancer Center at Providence Hospital, Mobile, Alabama, United States

🇺🇸

Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, United States

and more 581 locations

Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer

First Posted Date
2009-11-05
Last Posted Date
2021-10-25
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
141
Registration Number
NCT01008150
Locations
🇺🇸

Loma Linda University Medical Center, Loma Linda, California, United States

🇺🇸

Kaiser Permanente-San Diego, San Diego, California, United States

🇺🇸

CCOP - Colorado Cancer Research Program, Inc., Denver, Colorado, United States

and more 38 locations

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Conditions
Breast Cancer
First Posted Date
2009-08-27
Last Posted Date
2015-05-08
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
1881
Registration Number
NCT00967239

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

Withdrawn
Conditions
Breast Cancer
Fatigue
First Posted Date
2009-06-04
Last Posted Date
2013-01-11
Lead Sponsor
NSABP Foundation Inc
Registration Number
NCT00914043

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

First Posted Date
2009-04-24
Last Posted Date
2022-04-20
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
1613
Registration Number
NCT00887536
Locations
🇺🇸

Birmingham Hematology and Oncology, Birmingham, Alabama, United States

🇺🇸

Birmingham Hematology and Oncology - Brookwood, Birmingham, Alabama, United States

🇺🇸

Birmingham Hematology and Oncology - Princeton, Birmingham, Alabama, United States

and more 494 locations

A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver

Phase 2
Completed
Conditions
Metastatic Colorectal Cancer
Interventions
First Posted Date
2008-12-05
Last Posted Date
2021-10-06
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
20
Registration Number
NCT00803647
Locations
🇺🇸

Loma Linda University Medical Center, Loma Linda, California, United States

🇺🇸

St. Joseph Hospital, Orange, California, United States

🇺🇸

Kaiser Permanente-San Diego, San Diego, California, United States

and more 20 locations
© Copyright 2025. All Rights Reserved by MedPath